Authors

• Matthias Behrens (ORCID: https://orcid.org/0000-0001-5425-8144)
• Annette Aigner (ORCID: https://orcid.org/0000-0003-4891-8921)
• Christian W. Keller (ORCID: https://orcid.org/0000-0003-2276-0003)
• Lea Gerischer (ORCID: https://orcid.org/0000-0001-5746-068X)
• Luisa Klotz (ORCID: https://orcid.org/0000-0001-5439-9633)
• Jan D. Lünemann (ORCID: https://orcid.org/0000-0002-3007-708X)
• Sarah Hoffmann (ORCID: https://orcid.org/0000-0001-9549-2594)
• Meret Herdick (ORCID: https://orcid.org/0000-0003-0119-9499)
• Heinz Wiendl (ORCID: https://orcid.org/0000-0003-4310-3432)
• Frauke Stascheit (ORCID: https://orcid.org/0000-0001-5306-7880)
• John Tzartos (ORCID: https://orcid.org/0000-0002-8153-5300)
• Andreas Meisel (ORCID: https://orcid.org/0000-0001-7233-5342)
• Sophie Lehnerer (ORCID: https://orcid.org/0000-0001-9007-027X)
• Maike Stein (ORCID: https://orcid.org/0009-0002-1514-8385)
• Konstantinos Lazaridis (ORCID: https://orcid.org/0000-0003-4386-2578)
• Paolo Doksani (ORCID: https://orcid.org/0009-0009-5381-5995)
• Carla Daiane Ferreira de Sousa (ORCID: https://orcid.org/0009-0001-3685-3422)

Institutions

• Humboldt-Universität zu Berlin (DE)

Publication Details

Journal

Neurology Neuroimmunology & Neuroinflammation

Published

2024-11-27

DOI

https://doi.org/10.1212/nxi.0000000000200331

Citations

14

Primary Topic

Myasthenia Gravis and Thymoma

Type

article

Field-Weighted Citation Impact

5.17

Funders

• Bristol-Myers Squibb
• Sanofi
• Biogen
• Teva Pharmaceutical Industries
• Alexion Pharmaceuticals
• Argenx
• Moderna
• Deutsche Forschungsgemeinschaft
• Fondazione Cariplo
• Westfälische Wilhelms-Universität Münster
• Einstein Stiftung Berlin
• Idorsia Pharmaceuticals
• Grifols
• EMD Serono
• UCB Pharma